“Global Pricing and Market Access complements KMK’s broad suite of offerings and expands the portfolio of strategic support that KMK provides to our Life Science clients. We have an experienced team of market access professionals, working with a flexible and rigorous approach to solve your toughest problems.” - Stephen Deitch
Stephen, our Global Head of Market Access, is a crucial asset in driving and shaping KMK’s Pricing & Market Access team. With his extensive 30+ years of experience in healthcare and life sciences, Stephen is skilled at creating innovative strategies that help our clients achieve the best sustainable value, price and breadth of access, using rigorous evidence-based insights and analysis. He, and his team at KMK, leverage expertise across a broad range of therapeutic areas, markets and healthcare systems to collaborate effectively with strategic leaders in Life Sciences to deliver the value of innovative medicines for patients.
Areas of Expertise
Stephen brings experience from a varied career as a healthcare professional, payer, policy advisor, and strategy consultant to deliver and communicate value to global stakeholders and decision makers.
He has experience in developing global pricing strategies, innovative contracting approaches, effective global value communications, and supporting pricing and market access capabilities for a broad range of small to large Life Science companies. He possesses a wealth of qualitative and quantitative market research knowledge across a diverse range of therapy areas and has played a pivotal role in all stages of the product lifecycle development, making a profound impact in both developed and developing markets.
Stephen qualified as a pharmacist in 1987, spending 17 years in the UK NHS as a Payer and Executive Director. In 2011, he ventured into a senior leadership role with the global consulting team at IMS Health (now IQVIA), and in 2017, joined Charles River Associates as a Vice President.